Perkins Capital Management Inc Journey Medical Corp Transaction History
Perkins Capital Management Inc
- $102 Million
- Q2 2024
A detailed history of Perkins Capital Management Inc transactions in Journey Medical Corp stock. As of the latest transaction made, Perkins Capital Management Inc holds 22,000 shares of DERM stock, worth $124,300. This represents 0.12% of its overall portfolio holdings.
Number of Shares
22,000
Previous 22,000
-0.0%
Holding current value
$124,300
Previous $80,000
55.0%
% of portfolio
0.12%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding DERM
# of Institutions
37Shares Held
3.11MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.89 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA310KShares$1.75 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.295KShares$1.67 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny264KShares$1.49 Million0.0% of portfolio
-
American Financial Group Inc180KShares$1.02 Million0.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $65.5M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...